Evgen Pharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Evgen Pharma generated cash of -$4,029,000, which is less than the previous year. Cash used in financing activities reached the amount of $0 last year. Net change in cash is therefore $490,000.
Cash Flow
| 2016 | -1.56M | -2.04M | 8.56M |
|---|---|---|---|
| 2018 | -2.34M | -7K | 2.11M |
| 2020 | -2.57M | -1K | 4.67M |
| 2021 | -2.92M | -6.00M | 10.39M |
| 2023 | -4.02M | 4.51M | 0 |
EVG.L Cash Flow Statement (2015 – 2022)
| 2022 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|
Cash at beginning of period | 4.51M | 4.13M | 2.03M | 3.85M | 163K |
Operating activities | |||||
Net income | -4.04M | -2.67M | -2.71M | -2.58M | -3.13M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 13K | 18K | 21K | 21K | 8K |
Stock-based compensation expense | 157K | 0 | 168K | 111K | 801K |
| Deferred income tax benefit | 157K | 0 | 168K | 111K | 801K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | -91K | -39K | -61K | 7K | -47K |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 104K |
Cash generated by operating activities | -4.02M | -2.92M | -2.57M | -2.34M | -1.56M |
Investing activities | |||||
Purchases Of Investments | 0 | -6M | 0 | 0 | -2.00M |
Investments In Property Plant And Equipment | -1K | -5K | -1K | -7K | -6K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 4.51M | -6.00M | -1K | -7K | -2.04M |
Financing activities | |||||
Common Stock Issued | 0 | 10.39M | 4.67M | 2.11M | 8.56M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 0 | 10.39M | 4.67M | 2.11M | 8.56M |
Net Change In Cash | 490K | 1.46M | 2.09M | -233K | 4.95M |
Cash at end of period | 5M | 5.59M | 4.13M | 3.62M | 5.12M |
| Data source | Data source | Data source | Data source | Data source |